Zobrazeno 1 - 10
of 444
pro vyhledávání: '"Jack Ashton"'
Autor:
Schmidt, RichardA.1,2 (AUTHOR) raschmidt@hp-research.com
Publikováno v:
Journal of Motor Behavior. Jan/Feb2011, Vol. 43 Issue 1, p83-84. 2p.
Autor:
David M. Hyman, José Baselga, Sarat Chandarlapaty, Barry S. Taylor, Maurizio Scaltriti, Udai Banerji, Gaia Schiavon, Vicky Rowlands, Martin Pass, Michele Moschetta, Robert McEwen, Rhiannon Maudsley, Justin P.O. Lindemann, Joana Hauser, Andrew Foxley, Elza C. de Bruin, Claire Corcoran, Des D. Cashell, Alan Barnicle, Jack Ashton, Helen J. Ambrose, Laura Biganzoli, Marie-Paule Sablin, Ingrid A. Mayer, Eva M. Ciruelos, Mafalda Oliveira, Kenji Tamura, Lillian M. Smyth
Supplementary Figure 1. Participant Flow Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f3ddb7682626f66115790cb0108aba
https://doi.org/10.1158/1078-0432.22476300.v1
https://doi.org/10.1158/1078-0432.22476300.v1
Autor:
David M. Hyman, José Baselga, Sarat Chandarlapaty, Barry S. Taylor, Maurizio Scaltriti, Udai Banerji, Gaia Schiavon, Vicky Rowlands, Martin Pass, Michele Moschetta, Robert McEwen, Rhiannon Maudsley, Justin P.O. Lindemann, Joana Hauser, Andrew Foxley, Elza C. de Bruin, Claire Corcoran, Des D. Cashell, Alan Barnicle, Jack Ashton, Helen J. Ambrose, Laura Biganzoli, Marie-Paule Sablin, Ingrid A. Mayer, Eva M. Ciruelos, Mafalda Oliveira, Kenji Tamura, Lillian M. Smyth
Purpose:The activating mutation AKT1E17K occurs in approximately 7% of estrogen receptor–positive (ER+) metastatic breast cancer (MBC). We report, from a multipart, first-in-human, phase I study (NCT01226316), tolerability and activity of capivaser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c1b1cc28095071714876d36a725e47
https://doi.org/10.1158/1078-0432.c.6529365.v1
https://doi.org/10.1158/1078-0432.c.6529365.v1
Autor:
David M. Hyman, José Baselga, Sarat Chandarlapaty, Barry S. Taylor, Maurizio Scaltriti, Udai Banerji, Gaia Schiavon, Vicky Rowlands, Martin Pass, Michele Moschetta, Robert McEwen, Rhiannon Maudsley, Justin P.O. Lindemann, Joana Hauser, Andrew Foxley, Elza C. de Bruin, Claire Corcoran, Des D. Cashell, Alan Barnicle, Jack Ashton, Helen J. Ambrose, Laura Biganzoli, Marie-Paule Sablin, Ingrid A. Mayer, Eva M. Ciruelos, Mafalda Oliveira, Kenji Tamura, Lillian M. Smyth
Supplementary Figure 3. AKT1E17K Allele Frequency (AF) Distribution and Median AF for patients with available ctDNA NGS data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc68c5e9ff3cae038afb89d5bd3f604
https://doi.org/10.1158/1078-0432.22476294
https://doi.org/10.1158/1078-0432.22476294
Autor:
David M. Hyman, José Baselga, Sarat Chandarlapaty, Barry S. Taylor, Maurizio Scaltriti, Udai Banerji, Gaia Schiavon, Vicky Rowlands, Martin Pass, Michele Moschetta, Robert McEwen, Rhiannon Maudsley, Justin P.O. Lindemann, Joana Hauser, Andrew Foxley, Elza C. de Bruin, Claire Corcoran, Des D. Cashell, Alan Barnicle, Jack Ashton, Helen J. Ambrose, Laura Biganzoli, Marie-Paule Sablin, Ingrid A. Mayer, Eva M. Ciruelos, Mafalda Oliveira, Kenji Tamura, Lillian M. Smyth
Supplementary tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a0265a5795450271c65b9e3919ea10
https://doi.org/10.1158/1078-0432.22476291.v1
https://doi.org/10.1158/1078-0432.22476291.v1
Autor:
Ingrid A. Mayer, Sarat Chandarlapaty, Gaia Schiavon, Vicky Rowlands, Martin Pass, Elza C. de Bruin, Helen Ambrose, Claire Corcoran, Andrew Foxley, Kenji Tamura, David M. Hyman, Maurizio Scaltriti, Eva Ciruelos, Jack Ashton, José Baselga, Lillian M. Smyth, Joana Hauser, Justin P.O. Lindemann, Des D. Cashell, Michele Moschetta, Robert McEwen, Mafalda Oliveira, Barry S. Taylor, Udai Banerji, Rhiannon Maudsley, Alan Barnicle, Laura Biganzoli, Marie-Paule Sablin
Publikováno v:
Clinical Cancer Research. 26:3947-3957
Purpose:The activating mutation AKT1E17K occurs in approximately 7% of estrogen receptor–positive (ER+) metastatic breast cancer (MBC). We report, from a multipart, first-in-human, phase I study (NCT01226316), tolerability and activity of capivaser
Autor:
Michele Panuccio, Nicolantonio Agostini, Ugo Mellone, Giuseppe Lucia, Jack-Ashton Booth, Steven Wilson, Gianpasquale Chiatante, Simone Todisco
Publikováno v:
Rivista Italiana di Ornitologia - Research in Ornithology, Vol 82, Iss 1-2 (2012)
Observations on the autumn migration of raptors were carried out on the Calabrian Appennines in the area where the Italian peninsula is only 30 km wide. We used three different watch points at the same time between 24 August and 12 September 2005 and
Externí odkaz:
https://doaj.org/article/1e14e3f065b64656baecd0a66b6b8ce5
Publikováno v:
Clinical Cancer Research. 27:PO-032
Prostate cancer (PCa) is the 2nd most prevalent cancer in men and has poor patient outcome upon transition from localized disease to the castration-resistant and metastatic state. Numerous studies have indicated intratumoral hypoxia as a key driver i
Autor:
Lillian M, Smyth, Kenji, Tamura, Mafalda, Oliveira, Eva M, Ciruelos, Ingrid A, Mayer, Marie-Paule, Sablin, Laura, Biganzoli, Helen J, Ambrose, Jack, Ashton, Alan, Barnicle, Des D, Cashell, Claire, Corcoran, Elza C, de Bruin, Andrew, Foxley, Joana, Hauser, Justin P O, Lindemann, Rhiannon, Maudsley, Robert, McEwen, Michele, Moschetta, Martin, Pass, Vicky, Rowlands, Gaia, Schiavon, Udai, Banerji, Maurizio, Scaltriti, Barry S, Taylor, Sarat, Chandarlapaty, José, Baselga, David M, Hyman
Publikováno v:
Clin Cancer Res
PURPOSE: The activating mutation AKT1(E17K) occurs in ~7% of ER+ metastatic breast cancer (MBC). We report, from a multipart, first-in-human, Phase I study (NCT01226316), tolerability and activity of capivasertib, an oral AKT inhibitor, as monotherap
Autor:
Robert G. Bristow, Jack Ashton
Publikováno v:
The British Journal of Radiology
Ashton, J & Bristow, R 2020, ' Bad neighbours : hypoxia and genomic instability in prostate cancer ', The British journal of radiology, pp. 20200087 . https://doi.org/10.1259/bjr.20200087
Ashton, J & Bristow, R 2020, ' Bad neighbours : hypoxia and genomic instability in prostate cancer ', The British journal of radiology, pp. 20200087 . https://doi.org/10.1259/bjr.20200087
Prostate cancer (PCa) is a clinically heterogeneous disease and has poor patient outcome when tumours progress to castration-resistant and metastatic states. Understanding the mechanistic basis for transition to late stage aggressive disease is vital